These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 19072688)

  • 1. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
    Khan MT; Fuskevåg OM; Sylte I
    J Med Chem; 2009 Jan; 52(1):48-61. PubMed ID: 19072688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition.
    Englert L; Silber K; Steuber H; Brass S; Over B; Gerber HD; Heine A; Diederich WE; Klebe G
    ChemMedChem; 2010 Jun; 5(6):930-40. PubMed ID: 20394106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases.
    Khan MT; Khan R; Wuxiuer Y; Arfan M; Ahmed M; Sylte I
    Bioorg Med Chem; 2010 Jun; 18(12):4317-27. PubMed ID: 20494587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico fragment-based discovery of DPP-IV S1 pocket binders.
    Rummey C; Nordhoff S; Thiemann M; Metz G
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital method.
    Hirakawa T; Fujita S; Ohyama T; Dedachi K; Khan MT; Sylte I; Kurita N
    J Mol Graph Model; 2012 Mar; 33():1-11. PubMed ID: 22112671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
    Miguet L; Zervosen A; Gerards T; Pasha FA; Luxen A; Distèche-Nguyen M; Thomas A
    J Med Chem; 2009 Oct; 52(19):5926-36. PubMed ID: 19746934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
    Jenkins JL; Shapiro R
    Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking methods for structure-based library design.
    Cavasotto CN; Phatak SS
    Methods Mol Biol; 2011; 685():155-74. PubMed ID: 20981523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.
    Shen J; Wendoloski J
    Protein Sci; 1995 Mar; 4(3):373-81. PubMed ID: 7795520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the action of thermolysin.
    Tronrud DE; Roderick SL; Matthews BW
    Matrix Suppl; 1992; 1():107-11. PubMed ID: 1480010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical investigation of tight-binding thermolysin inhibitors.
    Shen J
    J Med Chem; 1997 Aug; 40(18):2953-8. PubMed ID: 9288178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budget.
    Maiorov V; Sheridan RP
    J Chem Inf Model; 2005; 45(4):1017-23. PubMed ID: 16045296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay.
    Xu W; Chen G; Liew OW; Zuo Z; Jiang H; Zhu W
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3188-92. PubMed ID: 19447035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
    Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
    J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
    Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
    J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
    J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.